November 19, 2020 09:00 - 10:15 ET
In this five-part series we will bring together expertise from across the firm to cover developments that span the complete lifecycle of this industry’s complex business model—from financing and procurement to regulation and litigation.
Procurement is a critical step in the life cycle for life sciences business models, and the centralized procurement of pharmaceutical products and medical devices by hospitals, health authorities and group procurement organizations presents opportunities and challenges. Grant Worden, Tom Yeo and Phil Symonds will discuss the legal framework for the procurement process, including common law, trade treaties and other procurement rules. The panel will also apply their on-the-ground experience to share practical insights on the procurement process, including responding to RFPs, “value adds”, rebates, limited tendering (sole source contracts), contract extensions, debriefing, bid protests and more.
9:00 a.m. Webinar opens
9:15 - 10:15 a.m. Presentation
Ontario: This program is eligible for up to 1.0 Substantive hour.
New York: This program contains 1.0 Areas of Professional Practice Credit.
Sessions in this series:
Session 1: Navigating (and challenging) a changing life sciences regulatory environment
Session 2: Life sciences product liability litigation: managing risks and anticipating trends
Session 3: The latest developments in life sciences IP litigation
Session 4: Life sciences and centralized procurement: navigating the process and responding to RFPs
Session 5: Financing life sciences on both sides of the border